[CIS PIDD] APECED & lung transplantation

Elie Haddad eliehaddad55 at gmail.com
Tue Jul 31 23:22:55 EDT 2012


Hi Megan,
usually we decide based on symptoms/need for increase steroids. In this case, it turned out that almost like a clock, the autoimmunity re-occurred every 6 to 7 months and after 3 relapses, we decided to give Rituximab every 6 months (1 dose), anyways the patient did not want to wait for the relapses anymore.
It is true that generally, after a treatment by Rituximab for an autoimmune disorder, the relapses occur together with the reappearance of circulating B cells, but I have seen in many cases relapses without (apparent) B cell recovery, and also in many cases B cell recovery without relapse.
Therefore, I look at B cells recovery, but I don't decide based on this.
Also, if the patient has already relapsed once after Rituximab, another relapse is likely to occur after the next cycle, but long lasting remissions have been observed even after the second or the third cycle of Rituximab. In addition, I always hesitate to give systematically Rituximab, given the possible risk of PML. I know however that many adult patients with RA receive Rituximab every 6 to 12 months, and maybe we are too frightened by this PML, but as always, it is a question of risk/benefice ratio and a patient whose life is changed thank to Rituximab will beg you to give him/her this treatment systematically (like our patient did).
I also look at B cell function and I don't hesitate to give Immunoglobulins if Igs decrease, or if I consider the patient being deeply immunosuppressed (very subjective I admit), or if the patient is treated systematically by Rituximab.
I hope it will help, and maybe other colleagues who gave Rituximab in APECED, or who are frequent prescribers of Rituximab, could share their experience.
All the best
Elie


> Elie Haddad, MD, PhD,

> Professor of Pediatrics, University of Montreal,

> Head, Pediatric Immunology and Rheumatology Division,

> CHU Sainte-Justine, 3175 Cote Sainte-Catherine

> Montreal, QC, H3T 1C5, Canada

> Ph: 1 514 345 4713

> fax: 1 514 345 4897

> e-mail: elie.haddad at umontreal.ca



On 2012-07-31, at 13:18, "Cooper, Megan" <Cooper_M at kids.wustl.edu> wrote:


> Hi Elie,

>

> I was wondering how often you are giving Rituximab to your patient with APECED. I have a young patient with APECED who has improved after rituximab, but I’ve been wondering how often to give it - yearly, when B cells return, or based on symptoms/need for increased steroids.

>

> Thanks,

>

> Megan

>

> Megan A. Cooper, MD, PhD

> Assistant Professor, Pediatrics

> Division of Rheumatology

> Washington University School of Medicine

> Cooper_m at kids.wustl.edu

> Lab website: http://research.peds.wustl.edu/Default.aspx?alias=research.peds.wustl.edu/Labs/Cooper_M

> (lab office) 314-286-0262

> (fax) 314-286-2895

>

>

>

> From: pagid-bounces at list.clinimmsoc.org [mailto:pagid-bounces at list.clinimmsoc.org] On Behalf Of Elie Haddad

> Sent: Thursday, July 26, 2012 8:08 AM

> To: pagid at list.clinimmsoc.org

> Subject: Re: [CIS PIDD] APECED & lung transplantation

>

> Dear Desa,

> I think lung transplantation will be tough in your case, and the logical idea to do lung and HSCT with the same donor does not seem very feasible.

> However, about Rituximab, I would advise you to try it in your patient. We've had a patient with APECED and it worked during many years for her multiple autoimmunity and the patient does not want to stop it since she says it's the best treatment she ever had and all her endocrinological and metabolic disturbances are stabilized by Rituximab. Will it work also for interstitial lung disease ? I don't know, but the idea to do like in GLILD associated with CVID with Rituximab and Imuran seems a logical option. I would say you have not much lo loose.

> Interestingly, (and it was in 2006) the patient told me that after Rituximab, her severe candidiasis vanished. To tell you the truth, I thought it was "psychological". Before giving Rituximab, I was concerned by this candidiasis, but we felt that killing B cells should not be too dangerous for her candidiasis. However, we did not think that it would cure her candidiasis. Now that we know that there are anti-IL-17 autoantibodies in this disease, it sounds logical. Therefore, Rituximab maybe will help for lung autoimmunity and maybe will help for clearing the candidiasis before the transplantation if you decide to do it.

> I hope it will help

> All the best

> Elie

>

>

> Elie Haddad, MD, PhD,

> Professor of Pediatrics, University of Montreal,

> Head, Pediatric Immunology and Rheumatology Division,

> CHU Sainte-Justine, 3175 Cote Sainte-Catherine

> Montreal, QC, H3T 1C5, Canada

> Ph: 1 514 345 4713

> fax: 1 514 345 4897

> e-mail: elie.haddad at umontreal.ca

>

>

>

>

>

> Le 2012-07-26 à 04:47, Desa Lilic a écrit :

>

>

> Thnx for reply. I am aware of a clinical trial in Great Ormond Street (GOS - London) of thymic transplants in Di George but not in APECEDs

>

> best

> desa

> From: pagid-bounces at list.clinimmsoc.org [pagid-bounces at list.clinimmsoc.org] on behalf of Church, Joseph [JChurch at chla.usc.edu]

> Sent: 25 July 2012 18:18

> To: pagid at list.clinimmsoc.org

> Subject: Re: [CIS PIDD] APECED & lung transplantation

>

> Theoretically, a thymus transplant should help and may be less risky than BMT. Unfortunately, I don't know any centers doing thymus transplant in APECED.

>

> Joe Church

> Children's Hospital Los Angeles

>

> From: pagid-bounces at list.clinimmsoc.org [mailto:pagid-bounces at list.clinimmsoc.org] On Behalf Of Desa Lilic

> Sent: Wednesday, July 25, 2012 3:30 AM

> To: pagid at list.clinimmsoc.org

> Subject: [CIS PIDD] APECED & lung transplantation

>

> Dear all,

>

> We have a young lady (26 yr) who has antibody deficiency & APECED - MC,

> HP, Addison, Autoimmune hepatitis, Lymphocytic Interstitial pneumonitis

> and autoimmune ovarian failure (see attached summary for more details).

>

> She has bad bronchiectasis ( being managed by our CF colleagues) with

> deteriorating lung function. Given the rapidity of deterioration in her

> lung function, the lung physicians are considering a referral

> for assessment for a lung transplant.

>

> 1. Are you aware any lung transplantations in the AIRE Mutation /

> APECED cohort ? (no published reports; I have liaised Jaakko

> Perheentupa - none in the Finnish cohort; )

> 1. Risk of invasive candidiasis with significant immunesuppresion (

> >aware of the report on renal transplant - there was no invasive

> >candidiasis)

> 1. Prognosis and life expectancy of a typical APECED patient with HP,

> Adr failure, autoimmune hepatitis. To make an reasoned case for lung

> >transplant

> 1. Thoughts on simultaneous Thymic transplant ?

> 1. Does the diagnosis of APECED in any way influence ones decision

> making process for eligibility of a lung transplant and risk benefit

> analysis ?

> 1. She is on Azathioprine for autoimmune hepatitis. One of the

> discussion points in our MDT was whether she would benefit form

> rituximab - to rx a potential ongoing interstitial inflammation in her

> lung.

>

> Would be grateful for your thoughts / comments.

> Desa

>

> Desa Lilic, MD, MSc, PhD, FRCPath

> Consultant & Clinical Senior Lecturer in Immunology

> Institute for Cellular Medicine

> 4th Fl Cookson Bldg

> Faculty of Medical Sciences

> University of Newcastle

> Newcastle upon Tyne, UK, NE2 4HH

>

> tel: ++ 44 (0)191 222 7244

> fax: ++ 44 (0)191 222 5455

> email: desa.lilic at ncl.ac.uk

>

>

> ---------------------------------------------------------------------

> CONFIDENTIALITY NOTICE: This e-mail message, including any attachments,

> is for the sole use of the intended recipient(s) and may contain confidential

> or legally privileged information. Any unauthorized review, use, disclosure

> or distribution is prohibited. If you are not the intended recipient, please

> contact the sender by reply e-mail and destroy all copies of this original message.

>

> ---------------------------------------------------------------------

>

>

>

> The materials in this email are private and may contain Protected Health Information. If you are not the intended recipient, be advised that any unauthorized use, disclosure, copying, distribution or the taking of any action in reliance on the contents of this information is strictly prohibited. If you have received this email in error, please immediately notify the sender via telephone or return email.

-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://seven.pairlist.net/pipermail/pagid/attachments/20120731/bd3b106a/attachment-0001.htm>


More information about the PAGID mailing list